Decisions to use surgical mesh in operations for pelvic organ prolapse: a question of geography?
|
|
- Jeffrey Higgins
- 5 years ago
- Views:
Transcription
1 International Urogynecology Journal ORIGINAL ARTICLE Decisions to use surgical mesh in operations for pelvic organ prolapse: a question of geography? Emil Karl Nüssler 1,2 & Emil Nüssler 1 & Jacob Kjær Eskildsen 3 & Mats Löfgren 1 Received: 18 July 2018 /Accepted: 2 October 2018 # The Author(s) 2018 Abstract Introduction and hypothesis Surgical mesh can reinforce damaged biological structures in operations for genital organ prolapse. When a method is new, scientific information is often contradictory. Individual surgeons may accept different observations as useful, resulting in conflicting treatment strategies. Additional scientific information should lead to increasing convergence. Methods Based on data from the Swedish National Quality Register of Gynecological Surgery, all patients who underwent their first recurrent anterior compartment prolapse operation between 2006 and 2017 were included (2758 patients). Surgical mesh was used in 56.5%. We analyzed inter-county disparities in and patterns of mesh use over 12 years. To minimize confounding, we selected a group of highly comparable patients where similar decision patterns could be expected. Results The use of mesh differed between counties by a factor of 11 ( %). Counties with low use of mesh continued with low use and counties with high use continued with high use. Conclusions Decisions regarding how to interpret existing scientific information about mesh implants in the early years of mesh use have led to Bcommunities of practice^ highly influenced by geographical factors. For 12 years, these groups have made disparate decisions and upheld them without measurable change toward consensus. The scientific learning process has stopped despite the abundance of new publications and the steady supply of new types of mesh. Ongoing disparity in surgeons choices in comparable patients has an adverse effect on clinical care. For the patient, this represents 12 years of a geographical lottery concerning whether mesh is used or not. Keywords Quality control. Surgical decision-making. Surgical mesh. Surgical learning Introduction Pelvic organ prolapse (POP) is common in women. Approximately 12% of women undergo an operation for prolapse [1 3], and high rates of recurrence in the range of 30 40% have been reported [4, 5]. To provide additional support for weakened or damaged biological tissue, special surgical meshes have been designed and have been in use since the * Emil Karl Nüssler emil.nussler@umu.se Department of Clinical Science, Obstetrics and Gynecology, Umeå University, Umeå, Sweden Gynop-registret, Norrlands universitetssjukhus, Umeå, Sweden Department of Management, School of Business and Social Sciences, Aarhus University, Aarhus, Denmark US Food and Drug Administration (FDA) approved the first mesh products in 2002 [6]. In contrast to the stringent requirements and formalized approaches for development of pharmaceuticals, there has never been a systematic scientific premarketing evaluation of mesh products. Faced with this situation, every surgeon individually has to investigate and validate available scientific information and accept the information gleaned as "current best knowledge." Consequently, treatment of POP with mesh remains controversial, and the decision when to use mesh is an unresolved challenge for gynecological surgeons and patients [7]. In 2011, the FDA released an update regarding the use of transvaginal surgical mesh, including a warning because of Bserious safety and effectiveness concerns^ [6]. A recent article[8] investigated 684,250 POP procedures performed in 2012 in 15 Organization for Economic Cooperation and Development (OECD) countries including Sweden. The article shows an extraordinary lack of uniformity across these 15 countries, with the median rate of surgical mesh utilization in the anterior compartment differing by a
2 factor of 7.9 (range %) and in the posterior compartment by a factor of 5.3 (range %). Monitoring results in prolapse surgery, the Swedish National Quality Register of Gynecological Surgery (GynOp) has seen an even larger continuing disparity in mesh use in Sweden. The optimal rate of mesh use cannot be both low and high at the same time. A large and persisting geographical disparity in mesh use in comparable patient groups will affect clinical care negatively. The aim of this article is: (1) to describe the geographical disparity over 12 years in the use of surgical mesh in operations for POP in Sweden; (2) to chart changes in patterns of Swedish gynecological surgeons mesh use over time. In an effort to make the hospital system more efficient, some counties have supported specialization in some hospitals, so differences in use of mesh at a hospital level may in some cases have organizational rather than medical reasons. The GynOp register shows that practically all (98.2%) patients who undergo a prolapse operation are operated on in the county they live in. This makes county results useful and robust as parameters for analysis of changes in mesh use. Based on this fact, we hypothesized that the proportion of POP operations with mesh county-wise, stratified by years, expresses the particular mesh policy for a particular year. Methods The Swedish National Quality Register of Gynecological Surgery The GynOp register includes all major gynecological operations performed in Sweden. Since 2006, GynOp has registered prolapse operations in detail on a national scale, including a 1-year follow-up of patients. Today, the register contains complete information on more than 56,000 prolapse procedures [9]. All patients are included in the register when a urogynecological procedure is decided. Yearly comparisons with the Swedish National Patient Register (where all Swedish surgical procedures are registered by law) shows that the GynOp coverage of Swedish prolapse operations from 2006 to 2008 has been around 75% and since 2009 it has continuously been > 95%. The data collection process includes both surgeon and patientderived data up to 1-year post-operation [10 12]. Data completeness regarding the use of mesh reported by the surgeons has been 100%. The GynOp registry provides all Swedish gynecological surgeons with yearly reports that include detailed information about the use of mesh in all types of prolapse surgery. The Swedish hospital system The Swedish hospital system is primarily organized at a county level. Swedish counties are fairly independent political units responsible for all health services within their boundaries [13]. Public hospitals are owned by the counties and financed by county taxes. There are a few private clinics that specialize primarily in elective surgery. These clinics are contracted to county councils and reimbursed by them for operations they perform on Swedish patients as all Swedes are covered under the national health system. Data The basic data used in this study include all POP operations registered prospectively and consecutively in GynOp from 1 January 2006 to 29 August 2017 in all, 56,120 operations. Patients with simultaneous operations for incontinence were not included. To minimize confounding, we selected a cohort in which the use of mesh was an accepted alternative and whose patients were so comparable that similar mesh decisions could be expected for them. We included only (1) patients who underwent only operations in the anterior compartment (anterior colporrhaphy). This is the most common operation in prolapse surgery and has a moderate level of difficulty. Patients with concomitant POP or non-pop operations were excluded. Additionally, (2) only healthy patients were included in the study (American Society of Anesthesiologists classification system for patients preoperative physical status, group one or two) [14]. Moreover, (3) all selected patients had a normal nondescended uterus. Since it can be argued that primary and recurrent POP operations represent different non-comparable patient groups, we (4) analyzed only patients undergoing their first recurrent operation, where the use of mesh is a generally accepted option; 96.7% of these patients had previously undergone Bnative tissue repair^ operations and 3.3% had received a mesh. We excluded four small counties and/or counties with low activity regarding POP surgery that reported fewer than 50 recurrent operations each (in total, 103 patients). This rigorous selection process resulted in a study group of 2758 eligible patients with recurrent POP surgery in the anterior compartment, operated on by 467 Swedish gynecological surgeons in 52 gynecological departments in 17 counties over 12 years where surgical mesh was used in 1559 patients (56.5%). All statistical analyses were performed using SPSS version 23 (IBM, Armonk, NY, USA).
3 Ethics The GynOp register was approved by the Ethics Committee of the University of Umeå, Umeå, Sweden (Dnr ). This study and the use of data from the register were approved by the Ethics Committee of the University of Umeå (Dnr M). Results The use of mesh in Sweden in operations for recurrent POP in the anterior compartment from 2006 to 2017 is shown in Fig. 1. At the national level, there was an increase in mesh use from 2006 to 2009 followed by a stable period, , at around 66% use. From 2013 (2 years after the FDA warning), there was a significant decrease (p = 0.000) to a new stable level of around 47%. At a county level, however, the use of mesh varied significantly, with a range of %. Figure 2 shows aggregated proportions of mesh use of the 17 counties over the entire period studied. To examine possible concealed changes over time, we performed a yearly ranking of counties mesh use where 1 = the lowest yearly county rank in mesh use and 17 = the highest yearly county rank. Figure 3 shows the mean rank of the 17 Swedish counties from 2010 to 2017; it indicates that the ranking in mesh use has been fairly stable over time. We performed a logistic regression of decision to use mesh, with the year of procedure, county, and interaction between year and county as explanatory variables. This analysis showed that the interaction effect was insignificant (p = 0.732), but the main effects year (p = 0.000) and county (p = 0.000) were both significant, with a Nagelkerke R-square of This substantiates that the use of mesh in the individual Swedish counties was independent of the year of surgery. The patient pool was practically identical across the Swedish counties concerning age, body mass index (BMI), and number of births. The size of the prolapse, however, varied substantially among the counties (Table 1). To facilitate the evaluation, we here express the size of the prolapse as the distance from the lowest point of the prolapse to the hymen. Mean prolapse in the different counties ranged from 0.03 cm inside to 2.52 cm outside the hymen. A test of the relationship between prolapse size and mesh use was insignificant (p =0.236). The different counties clearly had different strategies for,80 Proportion of mesh use,60,40,20, Year of operation Error bars: 95% CI Fig. 1 Proportions of mesh use in Sweden in operations for recurrent pelvic organ prolapse (POP) in the anterior compartment, ; 95% CI = 95% confidence interval
4 Fig. 2 Aggregated use of mesh in Swedish counties in operations for recurrent pelvic organ prolapse (POP) in the anterior compartment, Usage depicted in different shades of gray/black (light = low use; dark = high use) deciding to perform the procedure with respect to the size of the prolapse, but this had no bearing on their propensity to use mesh. Differences in mesh use were not attributable to patient characteristics. Discussion In this study, we analyzed 2758 consecutive POP operations over 12 years in comparable patients undergoing their first
5 17 Use of mesh in swedish coun es - ranking Mean rank Kronoberg Värmland Västerbo en Västernorrland Halland Uppsala Region Skåne Örebro Fig. 3 Mean rank of 17 Swedish counties regarding mesh use in operations for recurrent pelvic organ prolapse (POP) in the anterior compartment, (The figure gives the annual ranking of the counties, where 1 = the lowest yearly rank in mesh use and 17 = the highest rank) Jönköping Östergötland Dalarna Västra Götaland Kalmar Stockholm Gävleborg Norrbo en Västmanland recurrent POP surgery in the anterior compartment. The strength of this material is its size and completeness. A weakness of non-randomized studies like ours is the risk of confounding because prolapse operations have many levels of difficulty, ranging from simple procedures in day surgery to very advanced operations with unsolved reconstructive problems. We tried to compensate for this by strict selection, resulting in a group of highly comparable patients, thus avoiding confounding by special anatomical or technical/operative necessities and enabling us to evaluate surgeons decision making. At the national level, the use of mesh for recurrent cystocele has been fairly stable, giving an illusion of a certain consensus: in (which can be interpreted as the learning period), there was a stepwise increase in mesh use followed by two stable rates of around 66% from 2009 to 2012 and around 47% from 2013 onwards. Among the Swedish counties, however, the use of mesh differed by a factor of 11 (range %) in our observation period. The decision-making patterns in the individual counties remainedthe samefrom2006to2017: Countieswithlow use of mesh kept having low use and counties with high use continued high use through all 12 years. The FDAwarning led to a general decrease in mesh application, but the divergent pattern of mesh use prevailed. Evidence-based decision making is one of the core values of any health care organization, and the choice between different treatment options is assumed to be a rational process. Based on this principle, the greater the amount of valid scientific information physicians receive, the more structured their beliefs should become and the more convergence it is reasonable to expect in their decision-making patterns when treating comparable patients [15 17]. A decade ago, when decisions regarding mesh use were hampered by limited evidence, different surgeons drew different conclusions from the available information. This has led to clear Bcommunities of practice^ at the county level regarding interpretation of existing scientific information about the effectiveness of mesh.
6 Table 1 Patient characteristics by county Age, years (mean) 95% CI, age, years BMI (mean) 95% CI, BMI Parity (mean) 95% CI, parity Size of prolapse (cm) a 95% CI, size of prolapse Dalarna Gävleborg Halland Jönköping Kalmar Kronoberg Norrbotten Region Skåne Stockholm Uppsala Värmland Västerbotten Västernorrl Västmanland V. Götaland Örebro Östergötland Characteristics of patients operated on for recurrent cystocele in Sweden in , stratified by county BMI body mass index, 95% CI 95% confidence interval a Size of prolapse: distance from the lowest point of the prolapse to the hymen. Negative numbers indicate prolapse inside the introitus and positive numbers refer to prolapse outside the hymen In the last decade, the amount of scientific information on the use of mesh in POP has increased enormously. A PubMed search for B(Pelvic organ prolapse AND (mesh OR implant))^ in July 2018 yielded more than 2200 articles on the subject. A Cochrane review on transvaginal mesh compared with native tissue repair analyzed 37 randomized controlled trials of the intervention [18]. Since 2006, GynOp has distributed annual quality reports to all Swedish gynecological surgeons. The results are stratified according to the regional, county, and hospital level; consequently, the differences among counties are well known to the surgeons. Still, unaltered through 12 years, these groups have made mesh decisions in a clearly biased fashion, highly influenced by geographical factors, with unchanged disparity and with no measurable change toward consensus in the treatment of recurrent cystocele. It is not within the scope of this article to argue whether the use of mesh should be low or high. However, when the application of mesh ranges from 8.6 to > 95% in treatment of the same condition in comparable patients, the greater part of the underlying decisions must be suboptimal; the surgeons just cannot agree on which part. The fact that Swedish surgeons decision-making patterns have remained unchanged, despite mounting information on the conditions under which mesh is useful or not, suggests that Swedish surgeons decisions may be attributable to two factors: (1) The available scientific information may not qualify, or be interpreted, as evidence and/or (2) surgeons may read scientific information selectively. In the case of POP surgery, where surgeons have worked on patients and drawn their own conclusions regarding the conditions under which mesh is useful or not, this may make them susceptible to favoring information that supports their own prior hypotheses. Whether one or a combination of both of the above factors is the underlying reason, the result is disturbing and unsettling. A large disparity in surgeons decisions can be stimulating. It is an indication that there is potential for improvement and can be seen as a challenge to communicate and learn from each other. However, Swedish surgeons have maintained their contradictory positions for more than a decade with unchanged disparity. This indicates that the necessary scientific communication and learning process has stopped despite the abundance of publications and the steady supply of new types of mesh to replace withdrawn ones [19]. For surgeons, this shows an astonishing mismatch between learning needs and learning readiness. For patients, this represents 12 years of a geographical lottery concerning whether mesh is used or not. The extraordinary disparity in mesh use between 15 OECD countries, shown in a 2012 survey, indicates that this is by no means a Swedish problem alone, but an international challenge [8].
7 To invigorate the surgical learning process, it seems prudent to question the apparently biased ways we glean evidence from the available information. A sensible way forward would be to focus on increased communication across established consensus groups to enhance awareness of and curiosity about different solutions, increase willingness to learn from each other, and view differences as a possibility to learn and not a chance to dominate. In Sweden, this communication would need to take place between counties in the OECD, between member countries. Compliance with ethical standards Financial disclaimer The Swedish Association of Local Authorities and Regions supported the collection of data in the Swedish National Quality Register of Gynecological Surgery. The supporters had no role in the conduct of the study; management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. Conflicts of interest None. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. References 1. Fialkow MF, Newton KM, Lentz GM, Weiss NS. Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(3): Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4): Weber AM, Richter HE. Pelvic organ prolapse. Obstet Gynecol. 2005;106(3): Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015;26(11): Maher C, Feiner B, Baessler K, Schmid C. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev. 2013;(4):Cd American Food and Drug Administration. Alerts and notices: medical devices MedicalDevices/Safety/AlertsandNotices/UCM pdf. Accessed 19 Sept Davila GW, Baessler K, Cosson M, Cardozo L. Selection of patients in whom vaginal graft use may be appropriate. Int Urogynecol J. 2012;23(1): Haya N, Baessler K, Christmann-Schmid C, et al. Prolapse and continence surgery in countries of the Organization for Economic Cooperation and Development in Am J Obstet Gynecol. 2015;212(6):755.e GynOp. Babout the register^ about/about.htm. Accessed 31 Jan Nussler EK, Greisen S, Kesmodel US, Lofgren M, Bek KM, Glavind-Kristensen M. Operation for recurrent cystocele with anterior colporrhaphy or non-absorbable mesh: patient reported outcomes. Int Urogynecol J. 2013;24(11): Nussler E, Kesmodel US, Lofgren M, Nussler EK. Operation for primary cystocele with anterior colporrhaphy or non-absorbable mesh: patient-reported outcomes. Int Urogynecol J. 2015;26(3): Pakbaz M, Mogren I, Lofgren M. Outcomes of cystocele repair surgery in relation to different anesthesia methods. Acta Obstet Gynecol Scand. 2010;89(7): Peterson H, Leimanis A. The Swedish health-care system. System analysis of ambulatory care in selected countries: Springer; p Daabiss M. American Society of Anaesthesiologists physical status classification. Indian J Anaesth. 2011;55(2): Bayes T. A letter from the late Reverend Mr. Thomas Bayes, FRS to John Canton, MA and FRS. Phil Trans ( ). 1763;53: Camerer C. Bounded rationality in individual decision making. Exp Econ. 1998;1(2): Hogarth RM, Einhorn HJ. Order effects in belief updating: the belief-adjustment model. Cogn Psychol. 1992;24(1): Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Marjoribanks J. Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse. Cochrane Database Syst Rev. 2016;2:Cd Wall LL, Brown D. The perils of commercially driven surgical innovation. Am J Obstet Gynecol. 2010;202(1):30. e31 4.
INTERNATIONAL UROGYNAECOLOGICAL ASSOCIATION (IUGA) JOINT REPORT ON THE TERMINOLOGY FOR SURGICAL PROCEDURES TO
AN AMERICAN UROGYNECOLOGIC SOCIETY (AUGS) / INTERNATIONAL UROGYNAECOLOGICAL ASSOCIATION (IUGA) JOINT REPORT ON THE TERMINOLOGY FOR SURGICAL PROCEDURES TO TREAT PELVIC ORGAN PROLAPSE NEED FOR A WORKING
More informationOriginal article J Bas Res Med Sci 2015; 2(2): The incidence of recurrent pelvic organ prolapse: A cross sectional study
The incidence of recurrent pelvic organ prolapse: A cross sectional study Ashraf Direkvand-Moghadam 1, Ali Delpisheh 2, Azadeh Direkvand-Moghadam 3* 1. Psychosocial Injuries Research Center, Faculty of
More informationAnatomical and Functional Results of Pelvic Organ Prolapse Mesh Repair: A Prospective Study of 105 Cases
International Journal of Clinical Urology 2018; 2(1): 20-24 http://www.sciencepublishinggroup.com/j/ijcu doi: 10.11648/j.ijcu.20180201.14 Anatomical and Functional Results of Pelvic Organ Prolapse Mesh
More informationThe UK National Prolapse Survey: 10 years on
Int Urogynecol J (2018) 29:795 801 DOI 10.1007/s00192-017-3476-3 ORIGINAL ARTICLE The UK National Prolapse Survey: 10 years on Swati Jha 1 & Alfred Cutner 2 & Paul Moran 3 Received: 28 June 2017 /Accepted:
More informationPolypropylene vaginal mesh implants for vaginal prolapse
Polypropylene vaginal mesh implants for vaginal prolapse This statement has been developed and reviewed by the Women s Health Committee and approved by the RANZCOG Board and Council. A list of Women s
More informationAmerican Journal of Obstetrics and Gynecology
American Journal of Obstetrics and Gynecology 1 2 3 Recurrence of vaginal prolapse after total vaginal hysterectomy with concurrent vaginal uterosacral ligament suspension: comparison between normal-weight
More informationEndoFast Reliant System vs. Tension- free Mesh in a Sheep Model; three arm Comparative Study Assessing the Mechanical Pullout Force of Mesh Over Time
EndoFast Reliant System vs. Tension- free Mesh in a Sheep Model; three arm Comparative Study Assessing the Mechanical Pullout Force of Mesh Over Time Menachem Alcalay,M.D, Urogynecology unit, Sheba Medical
More informationWhat are we talking about? Symptoms. Prolapse Risk Factors. Vaginal bulge 1 Splinting. ?? Pelvic pressure Back pain 1 Urinary complaints 2
Options for Vaginal Prolapse What are we talking about? Michelle Y. Morrill, M.D. Director of Urogynecology The Permanente Medical Group Kaiser, San Francisco Assistant Professor, Volunteer Faculty Department
More informationComparative virulence and temperature preferences in Nosema apis and Nosema ceranae
Comparative virulence and temperature preferences in Nosema apis and Nosema ceranae Ingemar Fries, Eva Forsgren, Department of Ecology Swedish Univdersity of Agricultural Sciences 75007 Uppsala, Sweden
More informationUphold LITE Vaginal Support System 2015 Coding & Quick Reference Guide
Hospital Outpatient Coding Scenarios This guide contains specific information for two (2) common coding/reimbursement scenarios related to the use of the Uphold LITE Vaginal Support System when performed
More informationVaginal Parity and Pelvic Organ Prolapse
The Journal of Reproductive Medicine Vaginal Parity and Pelvic Organ Prolapse Lieschen H. Quiroz, M.D., Alvaro Muñoz, Ph.D., Stuart H. Shippey, M.D., Robert E. Gutman, M.D., and Victoria L. Handa, M.D.
More informationIncidence rate and risk factors for vaginal vault prolapse repair after hysterectomy
Int Urogynecol J (2008) 19:1623 1629 DOI 10.1007/s00192-008-0718-4 ORIGINAL ARTICLE Incidence rate and risk factors for vaginal vault prolapse repair after hysterectomy Patrick Dällenbach & Isabelle Kaelin-Gambirasio
More informationPredicting Treatment Choice for Patients With Pelvic Organ Prolapse
Predicting Treatment Choice for Patients With Pelvic Organ Prolapse Michael Heit, MD, MSPH, Chris Rosenquist, MD, Patrick Culligan, MD, Carol Graham, MD, Miles Murphy, MD, and Susan Shott, PhD OBJECTIVE:
More informationCitation for the original published paper (version of record):
http://www.diva-portal.org This is the published version of a paper published in International Urogynecology Journal. Citation for the original published paper (version of record): Bohlin, K S., Ankardal,
More informationLong-Term Effectiveness of Uterosacral Colpopexy and Minimally Invasive Sacral Colpopexy for Treatment of Pelvic Organ Prolapse
ORIGINAL ARTICLE Long-Term Effectiveness of Uterosacral Colpopexy and Minimally Invasive Sacral Colpopexy for Treatment of Pelvic Organ Prolapse Cecile A. Unger, MD, MPH, Matthew D. Barber, MD, MHS, Mark
More informationCurrent status in pelvic organ prolapse surgery: an evidence based review
Current status in pelvic organ prolapse surgery: an evidence based review Christian Falconer, MD, PhD Department of Obstetrics and Gynecology Danderyd University Hospital Stockholm, Sweden Finnish Society
More informationUniversity of Bristol - Explore Bristol Research
O'brien, S., Dua, A., & Vij, M. (2016). Practices in pelvic organ prolapse operations among surgeons: an international survey identifying needs for further research. International Urogynecology Journal,
More informationDENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery
Quality ID #428: Pelvic Organ Prolapse: Preoperative Assessment of Occult Stress Urinary Incontinence National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationOptions for Vaginal Prolapse. What is prolapse? What is prolapse? Disclosures 10/23/2013. Michelle Y. Morrill, M.D. None
Options for Vaginal Prolapse Disclosures None Michelle Y. Morrill, M.D. Director of Urogynecology Kaiser, San Francisco Assistant Professor, Volunteer Faculty Department of Ob/Gyn, UCSF What is prolapse?
More informationDear Mrs. Burch and editors of the BMJ,
Dear Mrs. Burch and editors of the BMJ, We are pleased that our manuscript entitled: Sacrospinous hysteropexy versus vaginal hysterectomy with uterosacral ligament suspension in women with uterine prolapse
More informationFDA and Mesh Complications in Vaginal Surgery
FDA and Mesh Complications in Vaginal Surgery Response to FDA Safety Communication dated July 13, 2011 To Our Patients and Women of the Community: As many of you are aware, on July 13, 2011, the FDA released
More informationSurgery for women with apical vaginal prolapse(review)
Cochrane Database of Systematic Reviews (Review) Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J.. Cochrane Database
More informationInternational Federation of Gynecology and Obstetrics
International Federation of Gynecology and Obstetrics COMMITTEE FOR UROGYNAECOLOGY AND PELVIC FLOOR MEMBER: TSUNG-HSIEN (CHARLES) SU, CHAIR (TAIWAN) DAVID RICHMOND, CO-CHAIR (UK) CHITTARANJAN PURANDARE,
More informationSACROSPINOUS LIGAMENT FIXATION, A SAFE AND EFFECTIVE WAY TO MANAGE VAGINAL VAULT PROLAPSE.A 10-YEAR OBSERVATIONAL STUDY OF CLINICAL PRACTICE
Original Article, A SAFE AND EFFECTIVE WAY TO MANAGE VAGINAL VAULT PROLAPSE.A 10-YEAR OBSERVATIONAL STUDY OF CLINICAL PRACTICE * ** Fauzia Rasool Memon, Mohamed Matar * Consultant Obstetrician and Gynecologist
More informationFemale Pelvic Prolapse: Considerations on Mesh Surgery and our Experience with Prolift Mesh in 84 Women with Complicated Pelvic Prolapses
Journal of Applied Medical Sciences, vol.5, no. 2, 2016, 19-30 ISSN: 2241-2328 (print version), 2241-2336 (online) Scienpress Ltd, 2016 Female Pelvic Prolapse: Considerations on Mesh Surgery and our Experience
More informationPRACTICE BULLETIN Female Pelvic Medicine & Reconstructive Surgery Volume 23, Number 4, July/August 2017
PRACTICE BULLETIN Number 176, April 2017 (Replaces Committee Opinion Number 513, December 2011) Pelvic Organ Prolapse Pelvic organ prolapse (POP) is a common, benign condition in women. For many women
More informationRates of colpopexy and colporrhaphy at the time of hysterectomy for prolapse
Original Research 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 Q1 Q8 UROGYNECOLOGY Rates of
More informationHYSTERECTOMY FOR BENIGN CONDITIONS
HYSTERECTOMY FOR BENIGN CONDITIONS UnitedHealthcare Oxford Clinical Policy Policy Number: SURGERY 104.7 T2 Effective Date: April 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS OF COVERAGE...
More informationCheck your prostate!
Almost every man Check your prostate! it can save your life Almost every man is affected sooner or later by some form of urological problem. This can mean a frequent, acute need to visit the toilet, leakage,
More informationMR imaging evaluation for the assessment of pelvic organ prolapse: a newer technique
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Dave A et al. Int J Reprod Contracept Obstet Gynecol. 2017 Aug;6(8):3400-3404 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20173451
More informationCHAU KHAC TU M.D., Ph.D.
CHAU KHAC TU M.D., Ph.D. Hue Central Hospital Vietnam LAPAROSCOPIC PROMONTOFIXATION FOR THE GENITAL PROLAPSE TREATMENT Chau Khac Tu MD.PhD. Hue central hospital CONTENT 3 1 INTRODUCTION 2 OBJECTIVE AND
More informationTraditional Anterior, Posterior, and Apical Compartment Repairs A Technique Based Review
Traditional Anterior, Posterior, and Apical Compartment Repairs A Technique Based Review Sandip Vasavada, MD Center for Female Urology and Pelvic Reconstructive Surgery The Glickman Urological and Kidney
More informationTITLE. A randomised controlled trial evaluating the use of polyglactin mesh, polydioxanone and polyglactin sutures for pelvic organ prolapse surgery
This is an electronic version of an article published in the Journal of Obstetrics and Gynaecology 2008;28(4):427-31 and is available online at http://www.informaworld.com/smpp/title~content=t713433887~link=cover
More informationFDA & Transvaginal Mesh: What Happened? What s Next?
FDA & Transvaginal Mesh: What Happened? What s Next? Matthew D. Barber, MD MHS Professor & Vice Chair for Clinical Research Obstetrics Gynecology & Women s Health Institute Disclosures I receive no grants,
More informationSurgical repair of vaginal wall prolapse using mesh
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Surgical repair of vaginal wall prolapse using mesh Vaginal wall prolapse happens when the normal support
More informationHYSTERECTOMY FOR BENIGN CONDITIONS
UnitedHealthcare Commercial Medical Policy HYSTERECTOMY FOR BENIGN CONDITIONS Policy Number: 2018T0572G Effective Date: September 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...
More informationDoes trocar-guided tension-free vaginal mesh (Prolift ) repair provoke prolapse of the unaffected compartments?
Int Urogynecol J (2010) 21:271 278 DOI 10.1007/s00192-009-1028-1 ORIGINAL ARTICLE Does trocar-guided tension-free vaginal mesh (Prolift ) repair provoke prolapse of the unaffected compartments? Mariëlla
More informationChildbirth after pelvic floor surgery: analysis of Hospital Episode Statistics in England,
DOI: 10.1111/1471-0528.12076 www.bjog.org Urogynaecology Childbirth after pelvic floor surgery: analysis of Hospital Episode Statistics in England, 2002 2008 A Pradhan, a DG Tincello, b R Kearney a a Department
More informationComplications from permanent synthetic mesh
Original Research Symptom Resolution After Operative Management of Complications From Transvaginal Mesh Erin C. Crosby, MD, Melinda Abernethy, MD, MPH, Mitchell B. Berger, MD, PhD, John O. DeLancey, MD,
More informationHealth Policy 120 (2016) Contents lists available at ScienceDirect. Health Policy
Health Policy 120 (2016) 1378 1382 Contents lists available at ScienceDirect Health Policy j ourna l ho me pa g e: www.elsevier.com/locate/healthpol Health Reform Monitor The 2015 National Cancer Program
More informationTo compare intermittent catheterization, sling mobilization and sling transection for treatment of
1 ABSTRACT: Objective: To compare intermittent catheterization, sling mobilization and sling transection for treatment of urinary retention after mid-urethral sling surgery. Methods: Data registered in
More informationKaranvir Virk M.D. Minimally Invasive & Pelvic Reconstructive Surgery 01/28/2015
Karanvir Virk M.D. Minimally Invasive & Pelvic Reconstructive Surgery 01/28/2015 Disclosures I have none Objectives Identify the basic Anatomy and causes of Pelvic Organ Prolapse Examine office diagnosis
More informationPelvic Floor. Reimbursement & Coding Guide
Pelvic Floor Reimbursement & Coding Guide Pelvic Floor Reimbursement and Coding Guide ACell Pelvic Floor Matrix products are biologically-derived devices comprised of porcine Urinary Bladder Matrix (UBM),
More informationDevelopment of the pelvic floor : implications for clinical anatomy Wallner, C.
UvA-DARE (Digital Academic Repository) Development of the pelvic floor : implications for clinical anatomy Wallner, C. Link to publication Citation for published version (APA): Wallner, C. (2008). Development
More informationIntroduction. Regarding the Section of the UPDATE Entitled Purpose
Time to Rethink: an Evidence-Based Response from Pelvic Surgeons to the FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ
More informationKeywords De novo prolapse, mesh, surgery, untreated compartment,
DOI: 10.1111/j.1471-0528.2011.03231.x www.bjog.org Urogynaecology Development of de novo prolapse in untreated vaginal compartments after prolapse repair with and without mesh: a secondary analysis of
More informationVaginal McCall culdoplasty versus laparoscopic uterosacral plication to prophylactically address vaginal vault prolapse
Vaginal McCall culdoplasty versus laparoscopic uterosacral to prophylactically address vaginal vault prolapse Niblock, K., Bailie, E., McCracken, G., & Johnston, K. (2017). Vaginal McCall culdoplasty versus
More informationCHRISTIAN FÜNFGELD 1, MARGIT STEHLE 1, BIRGIT HENNE 2, MARKUS GREBE 3, JAN OLIVER KAUFHOLD 4, DIRK WATERMANN 5, MATHIAS MENGEL 6 METHODS
Original article Quality of life and pelvic organ prolapse-related symptoms after pelvic floor reconstruction with a titanized polypropylene mesh for cystocele: long-term results in a 36 month follow-up
More informationConsidering Surgery for Pelvic Prolapse? Learn about minimally invasive da Vinci Surgery
Considering Surgery for Pelvic Prolapse? Learn about minimally invasive da Vinci Surgery The Surgery: Pelvic Prolapse Surgery If you have pelvic prolapse symptoms, your doctor may suggest medicine or lifestyle
More informationT h e C o m p l e t e Tr e a t m e n t o f P e l v i c F l o o r P r o l a p s e by Laparoscopy Technique, Tips and Tricks
T h e C o m p l e t e Tr e a t m e n t o f P e l v i c F l o o r P r o l a p s e by Laparoscopy Technique, Tips and Tricks R Botchorishvili, A Wattiez, G Mage, M Canis, B Rabischong, K Jardon, C Rivoire,
More informationABSTRACT. KEY WORDS antibiotics; prophylaxis; hysterectomy
Infectious Diseases in Obstetrics and Gynecology 8:230-234 (2000) (C) 2000 Wiley-Liss, Inc. Wound Infection in Gynecologic Surgery Aparna A. Kamat,* Leo Brancazio, and Mark Gibson Department of Obstetrics
More information2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Measure #428: Pelvic Organ Prolapse: Preoperative Assessment of Occult Stress Urinary Incontinence National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationChildbirth and prolapse: long-term associations with the symptoms and objective measurement of pelvic organ prolapse
DOI: 10.1111/1471-0528.12075 www.bjog.org Epidemiology Childbirth and prolapse: long-term associations with the symptoms and objective measurement of pelvic organ prolapse C Glazener, a A Elders, a C MacArthur,
More informationPL Narducci Department of Obstetrics and Gynecology General Hospital San Giovanni Battista Foligno, ITALY
NESA DAYS 2018 New European Surgical Academy Perugia, April 19-21, 2018 EXCELLENCE IN FEMALE SURGERY PROLAPSE RECONSTRUCTIVE SURGERY IN SEXUALLY ACTIVE WOMEN LAPAROSCOPIC ANTERIOR ABDOMINAL WALL COLPOPEXY
More informationUnderstanding Pelvic Organ Prolapse. Stephanie Pickett, MD, MS Female Pelvic Medicine and Reconstructive Surgery
Understanding Pelvic Organ Prolapse Stephanie Pickett, MD, MS Female Pelvic Medicine and Reconstructive Surgery Disclosures None I am the daughter of a physician assistant. Objectives List types of pelvic
More informationDENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery
Measure #428: Pelvic Organ Prolapse: Preoperative Assessment of Occult Stress Urinary Incontinence National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTY
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome
Quality ID #432: Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES:
More informationEffect of Anesthesia on Voiding Function After Tension-Free Vaginal Tape Procedure
Effect of Anesthesia on Voiding Function After Tension-Free Vaginal Tape Procedure M. Murphy, MD, M. H. Heit, MD, MSPH, L. Fouts, MD, C. A. Graham, MD, L. Blackwell, RN, and P. J. Culligan, MD OBJECTIVE:
More informationSafety and short term outcomes of a new truly minimallyinvasive mesh-less and dissection-less anchoring system for pelvic organ prolapse apical repair
ORIGINAL ARTICLE Vol. 43 (3): 533-539, May - June, 2017 doi: 10.1590/S1677-5538.IBJU.2016.0356 Safety and short term outcomes of a new truly minimallyinvasive mesh-less and dissection-less anchoring system
More informationMaximising effectiveness of healthcare spend a thought starter
Maximising effectiveness of healthcare spend a thought starter Dr Penelope Dash Partner, McKinsey & Co John Parkes Chief Executive, NHS Northamptonshire Objectives of this session and areas we will cover
More informationFernanda Santos*, Isabel Duarte**, António Correia**, António Santiago*** Centro Hospitalar de Leiria Hospital Santo André
Original Study/Estudo Original Transvaginal repair of genital prolapse with a Prolift system: complications and outcomes after 7 years of follow-up Tratamento cirúrgico do prolapso genital com sistema
More informationRecent advances in POP. Dr. Bernhard Uhl Department for Obstetrics and Gynecology St. Vinzenz-Hospital Dinslaken Germany
Recent advances in POP Dr. Bernhard Uhl Department for Obstetrics and Gynecology St. Vinzenz-Hospital Dinslaken Germany Level of pelvic floor support Level I apical Level II transverse/ horizontal Level
More informationTitle: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis.
Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis. Principal Investigator: Dick Menzies, MD Evidence base for treatment of INH resistant
More informationHigh failure rates after conventional surgeries for
Vaginal Mesh Contraction Definition, Clinical Presentation, and Management Benjamin Feiner, MD, and Christopher Maher, MD OBJECTIVE: While transvaginal polypropylene mesh is increasingly used in the management
More informationAnterior six arms prolene mesh for high stage vaginal prolapse: five years follow-up
ORIGINAL ARTICLE Vol. 43 (3): 525-532, May - June, 2017 doi: 10.1590/S1677-5538.IBJU.2016.0482 Anterior six arms prolene mesh for high stage vaginal prolapse: five years follow-up Luis Gustavo M. de Toledo
More informationSeventeen years follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence
Int Urogynecol J (2013) 24:1265 1269 DOI 10.1007/s00192-013-2090-2 ORIGINAL ARTICLE: EDITORS CHOICE Seventeen years follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence
More informationLars Jacobsson 1,2,3* and Jan Lexell 1,3,4
Jacobsson and Lexell Health and Quality of Life Outcomes (2016) 14:10 DOI 10.1186/s12955-016-0405-y SHORT REPORT Open Access Life satisfaction after traumatic brain injury: comparison of ratings with the
More informationLe fort s operation for prolapse uterus: A forgotten procedure
2017; 1(2): 52-56 ISSN (P): 2522-6614 ISSN (E): 2522-6622 Gynaecology Journal www.gynaecologyjournal.com 2017; 1(2): 52-56 Received: 12-09-2017 Accepted: 13-10-2017 Dr. Jasmine Lall 3 rd Year Resident,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal mesh background of, 84 85 Age as factor in PFDs, 8 Anal plugs in FI management in women, 107 Anterior compartment native tissue
More informationRandomized trial of fascia lata and polypropylene mesh for abdominal sacrocolpopexy: 5-year follow-up
DOI 10.1007/s00192-010-1249-3 ORIGINAL ARTICLE Randomized trial of fascia lata and polypropylene mesh for abdominal sacrocolpopexy: 5-year follow-up Susan B. Tate & Linda Blackwell & Douglas J. Lorenz
More informationLong-term follow-up of sacrocolpopexy mesh implants at two time intervals at least 1 year apart using 4D transperineal ultrasound
Ultrasound Obstet Gynecol 2017; 49: 398 403 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.15891 Long-term follow-up of sacrocolpopexy mesh implants at two time intervals
More informationDana Burlacu and Christine R Landon Leeds UK. A prospective study
The prevalence of benign joint hypermobility syndrome (BJHS) in women undergoing pelvic floor surgery for pelvic organ prolapse and incontinence and the risk of repeat surgery. A prospective study Dana
More informationMoneli Golara Consultant Obstetrician and Gynaecologist Royal Free NHS Trust Barnet Hospital
Moneli Golara Consultant Obstetrician and Gynaecologist Royal Free NHS Trust Barnet Hospital Pelvic Organ Prolapse (POP)- herniation of pelvic organs into vaginal walls Common Huge impact on daily activities
More informationFREEDOM OF INFORMATION ACT
FOI REF: 17/216 19 th May 2017 FREEDOM OF INFORMATION ACT I am responding to your request for information under the Freedom of Information Act. The answers to your specific questions are as follows: My
More information9/24/2015. Pelvic Floor Disorders. Agenda. What is the Pelvic Floor? Pelvic Floor Problems
Management of Pelvic Floor Disorders Doctor, I don t want THAT mesh! Agenda What are pelvic floor disorders (PFDs)? What are the treatment options? Expectant. Conservative. Surgical. How and when are grafts
More informationSURGICAL. How to manage the cuff at vaginal hysterectomy. For personal use only. Copyright Dowden Health Media TECHNIQUES
For mass reproduction, content licensing and permissions contact Dowden Health Media. How to manage the cuff at vaginal hysterectomy The high McCall culdoplasty and its modifications can prevent apical
More informationAN INTERNATIONAL CONTINENCE SOCIETY (ICS) / INTERNATIONAL UROGYNAECOLOGICAL ASSOCIATION (IUGA) JOINT REPORT ON THE TERMINOLOGY FOR CHILDBIRTH TRAUMA
AN INTERNATIONAL CONTINENCE SOCIETY (ICS) / INTERNATIONAL UROGYNAECOLOGICAL ASSOCIATION (IUGA) JOINT REPORT ON THE TERMINOLOGY FOR CHILDBIRTH TRAUMA NEED FOR A WORKING GROUP ON CHILDBIRTH TRAUMA A: Background
More informationInternational Urogynecological Association (IUGA) Observership Grant. Final Report
International Urogynecological Association (IUGA) 2009-10 Observership Grant Final Report Observership Grant Recipient: Renato Silva Martins 5 th Year Obstetrics and Gynaecology Resident at Coimbra s University
More informationTechnique of anterior colporrhaphy: a Dutch evaluation
Int Urogynecol J (2011) 22:557 561 DOI 10.1007/s00192-010-1353-4 ORIGINAL ARTICLE Technique of anterior colporrhaphy: a Dutch evaluation Ellen J. M. Lensen & Jackie A. Stoutjesdijk & Mariella I. J. Withagen
More informationPelvic Health Coding & Payment Quick Reference
Payer policies will vary and should be verified prior to treatment for limitations on diagnosis, coding or site of service requirements. The coding options listed within this guide are commonly used codes
More informationMedium-term follow-up on use of freeze-dried, irradiated donor fascia for sacrocolpopexy and sling procedures
Int Urogynecol J (2004) 15: 238 242 DOI 10.1007/s00192-004-1146-8 ORIGINAL ARTICLE Mary Pat FitzGerald Æ S. Renee Edwards Æ Dee Fenner Medium-term follow-up on use of freeze-dried, irradiated donor fascia
More informationStudy comparing 3 hour and 24 hour postoperative removal of bladder catheter and vaginal pack following vaginal surgery: a randomised controlled trial
Rajan et al. BMC Women's Health (2017) 17:78 DOI 10.1186/s12905-017-0431-x RESEARCH ARTICLE Open Access Study comparing 3 hour and 24 hour postoperative removal of bladder catheter and vaginal pack following
More informationFinland and Sweden and UK GP-HOSP datasets
Web appendix: Supplementary material Table 1 Specific diagnosis codes used to identify bladder cancer cases in each dataset Finland and Sweden and UK GP-HOSP datasets Netherlands hospital and cancer registry
More informationCommentary on NHS Digital. Retrospective Review of Surgery for Urogynaecological Prolapse and Stress Incontinence using Tape or Mesh, April 2018
Commentary on NHS Digital. Retrospective Review of Surgery for Urogynaecological Prolapse and Stress Incontinence using Tape or Mesh, April 2018 Nick Black Professor of Health Services Research Policy
More informationBard: Continence Therapy. Stress Urinary Incontinence. Regaining Control. Restoring Your Lifestyle.
Bard: Continence Therapy Stress Urinary Incontinence Regaining Control. Restoring Your Lifestyle. Stress Urinary Incontinence Urinary incontinence is a common problem and one that can be resolved by working
More informationHigh success rate and considerable adverse events of pelvic prolapse surgery with Prolift: A single center experience
Available online at www.sciencedirect.com ScienceDirect Taiwanese Journal of Obstetrics & Gynecology 52 (2013) 389e394 Short Communication High success rate and considerable adverse events of pelvic prolapse
More informationClinical Policy: Essure Removal Reference Number: CP.MP.131
Clinical Policy: Reference Number: CP.MP.131 Effective Date: 11/16 Last Review Date: 11/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationInterventional procedures guidance Published: 28 June 2017 nice.org.uk/guidance/ipg583
Sacrocolpopexy using mesh to repair vaginal vault prolapse Interventional procedures guidance Published: 28 June 2017 nice.org.uk/guidance/ipg583 Your responsibility This guidance represents the view of
More informationSurgical management of pelvic organ prolapse in women(review)
Cochrane Database of Systematic Reviews Surgical management of pelvic organ prolapse in women (Review) MaherC,FeinerB,BaesslerK,SchmidC MaherC,FeinerB,BaesslerK,SchmidC. Surgical management of pelvic organ
More informationCancer Incidence in Sweden 1998
STATISTICS HEALTH AND DISEASES 2000:4 Cancer Incidence in Sweden 1998 CENTRE FOR EPIDEMIOLOGY SVERIGES OFFICIELLA STATISTIK OFFICIAL STATISTICS OF SWEDEN Statistics - Health and Diseases Cancer Incidence
More informationSwedish gynecologists
Acta Obstetricia et Gynecologica. 2009; 88: 267274 ORIGINAL ARTICLE Attitudes to mode of hysterectomy Swedish gynecologists a survey-based study among PÄR PERSSON 1,2, THOMAS HELLBORG 1, JAN BRYNHILDSEN
More informationIs levator avulsion a predictor of cystocele recurrence following anterior vaginal mesh placement?
Ultrasound Obstet Gynecol 2013; 42: 230 234 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.12433 Is levator avulsion a predictor of cystocele recurrence following anterior
More informationEfficacy and Adverse Effects of Monarc Versus Tension-free Vaginal Tape Obturator: a Retrospective One-year Follow-up Study
Efficacy and Adverse Effects of Monarc Versus Tension-free Vaginal Tape Obturator: a Retrospective One-year Follow-up Study Yvonne KY CHENG MBChB, MRCOG William WK TO MBBS, M Phil, FRCOG, FHKAM (O&G) HX
More informationEvaluation of the single-incision Elevate system to treat pelvic organ prolapse: follow-up from 15 to 45 months
Int Urogynecol J (2015) 26:1341 1346 DOI 10.1007/s00192-015-2693-x ORIGINAL ARTICLE Evaluation of the single-incision Elevate system to treat pelvic organ prolapse: follow-up from 15 to 45 months Kuan-Hui
More information2012/13 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL)
E10d 2012/13 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL) SECTION B PART 1 - SERVICE SPECIFICATIONS Service Specification No.
More informationStop Coping. Start Living. Talk to your doctor about pelvic organ prolapse and sacrocolpopexy
Stop Coping. Start Living Talk to your doctor about pelvic organ prolapse and sacrocolpopexy Did you know? One in three women will suffer from a pelvic health condition in her lifetime. Four of the most
More informationHealth technology The use of tension-free vaginal tape (TVT) for the treatment of female stress urinary incontinence (SUI).
Cost effectiveness of tension-free vaginal tape for the surgical management of female stress incontinence Kilonzo M, Vale L, Stearns S C, Grant A, Cody J, Glazener C M, Wallace S, McCormack K Record Status
More informationThe incidence of mesh extrusion after vaginal incontinence and pelvic floor prolapse surgery
ORIGINAL ARTICLE The incidence of mesh extrusion after vaginal incontinence and pelvic floor prolapse surgery Seth Cohen, Elizabeth Kavaler Department of Urology, Lenox Hill Hospital, USA Correspondence:
More informationTitanised mesh implants for urogynaecology Transvaginal multi-arm meshes Incontinence tapes Instruments Laparoscopic meshes
Quality and Experience Titanised mesh implants for urogynaecology Transvaginal multi-arm meshes Incontinence tapes Instruments Laparoscopic meshes www.pfmmedical.com 1 Titanised Mesh Implants for Urogynaecology
More informationFrequency of urinary incontinence with Pelvic organ prolapse and associated factors
ORIGINAL ARTICLE Frequency of urinary incontinence with Pelvic organ prolapse and associated factors Dr. Raheela Mohsin 1, Dr.Ayesha Saba 2, Humera Ismail 3 1 Dr. Raheela Mohsin, Aga Khan University Hospital,
More information